002370 亚太药业
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--064612,3330
固定资产330,861-2.14%338,079364,755384,499430,506
在建工程298927.59%29340901
无形资产52,747-2.67%54,19559,20657,22251,572
商誉0--0000
其他非流动资产52,516-3.29%54,30549,55364,977131,952
436,421-2.28%446,608474,193519,030614,933

流动资产
货币资金776,7934.43%743,851720,475757,617821,113
应收账款89,445-6.15%95,31079,51089,05969,964
存货80,21714.38%70,12989,47595,20560,899
其他流动资产58,17326.82%45,87265,72162,96543,872
1,004,6295.18%955,160955,1801,004,845995,849

流动负债
短期借款30,027-0.10%30,05650,06050,0610
应付票据18,538--02,32030,3700
应付帐款48,0935.09%45,76549,47759,46153,926
其他流动负债333,891-1.97%340,61659,94782,491160,224
430,5493.39%416,436161,803222,383214,150
流动资产净值574,0806.56%538,724793,377782,462781,699
资产总额减流动负债1,010,5012.55%985,3321,267,5711,301,4921,396,631

非流动负债
长期借款0--0000
应付债券0--0639,477900,015861,581
其他非流动负债12,640-3.89%13,15147,220100,211102,089
12,640-3.89%13,151686,6961,000,226963,670

总权益
    实收股本739,6281.52%728,586609,171536,687536,618
    储备项目258,2336.01%243,595(28,297)(235,420)(103,657)
股东权益997,8612.64%972,181580,874301,267432,962
非控股权益0--0000